Literature DB >> 33352531

Sex-dependent immune response and lethality of COVID-19.

Albert Jiarui Li1, Xiajun Li2.   

Abstract

COVID-19 has spread to all countries around the world after it was first discovered in Wuhan of China at the end of 2019. It is caused by a novel coronavirus called SARS-CoV-2 with much semblance to SARS-CoV including the sequence homology and disease symptoms. It is reported to be more infectious than SARS-CoV due to higher binding affinities between its spike protein and the ACE2 receptor on cell surface. Despite this, its case fatality rate is much lower compared with that of SARS-CoV although it varies in different countries. However, the case fatality rate increases steadily with age and it is reported to be the highest in aged COVID-19 male patients in almost all countries. Consistent with these, females have higher antiviral immune responses. Males and females are different in inflammatory response and aberrantly hyperactive cytokines are the main lethal causes of COVID-19. Interestingly, the gene encoding the ACE2 receptor protein and some genes encoding the immune regulatory proteins such as TLR7 are located on X chromosome which is subject to X chromosome inactivation and sex hormone regulation. These may account for some sex-dependent immune responses and lethality observed in COVID-19 patients. In general, children are less likely to be infected with SARS-CoV-2 and only less than 1% of pediatric COVID-19 patients may die of COVID-19. However, the most severe pediatric cases become multisystem inflammatory syndrome that is similar to Kawasiki disease with features of viral infection. Since most infected kids were boys in China, there may be sex-dependent immune response in pediatric COVID-19 cases as well.
Copyright © 2020 The Author(s). Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ACE2; Age; COVID-19; Fatality; Immune; SARS-CoV-2; Sex; TLR7

Year:  2020        PMID: 33352531     DOI: 10.1016/j.scr.2020.102116

Source DB:  PubMed          Journal:  Stem Cell Res        ISSN: 1873-5061            Impact factor:   2.020


  6 in total

Review 1.  Immune Sexual Dimorphism: Connecting the Dots.

Authors:  Shani Talia Gal-Oz; Tal Shay
Journal:  Physiology (Bethesda)       Date:  2021-09-13

Review 2.  Immunological aspects and gender bias during respiratory viral infections including novel Coronavirus disease-19 (COVID-19): A scoping review.

Authors:  Sabitha Vadakedath; Venkataramana Kandi; Ranjan K Mohapatra; Venkata B K Pinnelli; Richa R Yegurla; Praveen R Shahapur; Vikram Godishala; Senthilkumar Natesan; Kranti S Vora; Khan Sharun; Ruchi Tiwari; Muhammad Bilal; Kuldeep Dhama
Journal:  J Med Virol       Date:  2021-05-19       Impact factor: 20.693

3.  The impact of calcitriol and estradiol on the SARS-CoV-2 biological activity: a molecular modeling approach.

Authors:  Alireza Mansouri; Rasoul Kowsar; Mostafa Zakariazadeh; Hassan Hakimi; Akio Miyamoto
Journal:  Sci Rep       Date:  2022-01-13       Impact factor: 4.379

4.  Zfp57 Exerts Maternal and Sexually Dimorphic Effects on Genomic Imprinting.

Authors:  Zhen Xu; Jiajia Shi; Yu Zhang; Yuhan Liu; Junzheng Zhao; Qian Chen; Chenglin Song; Shuhui Geng; Wei Xie; Feizhen Wu; Yun Bai; Yang Yang; Xiajun Li
Journal:  Front Cell Dev Biol       Date:  2022-02-02

5.  Masculinity, Perceived Vulnerability to COVID-19, and Adoption of Protective Behaviors.

Authors:  Michele Roccato; Maria Giuseppina Pacilli; Giovanni Orlando; Silvia Russo
Journal:  Sex Cult       Date:  2022-08-30

Review 6.  Diverse Immunological Factors Influencing Pathogenesis in Patients with COVID-19: A Review on Viral Dissemination, Immunotherapeutic Options to Counter Cytokine Storm and Inflammatory Responses.

Authors:  Ali A Rabaan; Shamsah H Al-Ahmed; Mohammed A Garout; Ayman M Al-Qaaneh; Anupam A Sule; Raghavendra Tirupathi; Abbas Al Mutair; Saad Alhumaid; Abdulkarim Hasan; Manish Dhawan; Ruchi Tiwari; Khan Sharun; Ranjan K Mohapatra; Saikat Mitra; Talha Bin Emran; Muhammad Bilal; Rajendra Singh; Salem A Alyami; Mohammad Ali Moni; Kuldeep Dhama
Journal:  Pathogens       Date:  2021-05-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.